Video - Heparin-induced thrombocytopenia
00:00 / 00:00
More Videos
06:26
Acute intermittent porphyria
11:39
Autoimmune hemolytic anemia
09:08
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
08:51
Sickle cell disease (NORD)
10:36
Folate (Vitamin B9) deficiency
10:26
Vitamin B12 deficiency
06:35
Alpha-thalassemia
06:33
Anemia of chronic disease
07:00
Beta-thalassemia
09:30
Iron deficiency anemia
06:52
Sideroblastic anemia
06:33
Anemia of chronic disease
06:36
Aplastic anemia
06:36
Aplastic anemia
04:44
Immune thrombocytopenia
05:07
Polycythemia vera (NORD)
Video Summary
Heparin-induced thrombocytopenia (HIT) is a rare but potentially life-threatening complication that can occur during the treatment course with heparin. HIT occurs when the body produces antibodies against heparin, which then attach to and damage platelets (the cells that help the blood clot). This can decrease the number of platelets in the blood (thrombocytopenia), which can cause easy bruising and bleeding.
For Institutions
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.
